nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse events following immunization with DTaP-IPV (Tetraxim) in school-aged children in Taiwan, 2017–2020
|
Kung, Yen-Hsin |
|
|
21 |
C |
p. |
artikel |
2 |
Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study
|
Rover, Marciane Maria |
|
|
21 |
C |
p. |
artikel |
3 |
Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi
|
Debellut, Frédéric |
|
|
21 |
C |
p. |
artikel |
4 |
COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature
|
Hyun Lim, Su |
|
|
21 |
C |
p. |
artikel |
5 |
COVID-19 vaccine or booster uptake and hesitancy for children aged 6 months–5 years in the United States: A national descriptive study using the household pulse survey between March and May 2023
|
Park, Chulwoo |
|
|
21 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
21 |
C |
p. |
artikel |
7 |
Global COVID-19 vaccine hesitancy among elderly: A systematic review
|
Law, M.C. |
|
|
21 |
C |
p. |
artikel |
8 |
HPV vaccine hesitancy among parents and caregivers of adolescents in Northern Nigeria
|
Yusuf, Korede K. |
|
|
21 |
C |
p. |
artikel |
9 |
Immunogenicities of vaccines including the immunoglobulin M-degrading enzyme of Streptococcus suis, rIde Ssuis , and protective efficacy against serotype 14 in piglets
|
Mayer, L. |
|
|
21 |
C |
p. |
artikel |
10 |
Lot quality assurance sampling for coverage evaluation of a new vaccine: A pilot study
|
Hora, Rhythm |
|
|
21 |
C |
p. |
artikel |
11 |
Mumps outbreak in Zimbabwe: The case for universal MMR vaccination in Africa
|
Gwinji, Phanuel Tawanda |
|
|
21 |
C |
p. |
artikel |
12 |
Parental motivations and perceived barriers to participating in pediatric vaccine clinical trials: Findings from the OCV-S trial in Nepal
|
Chapagain, Ram Hari |
|
|
21 |
C |
p. |
artikel |
13 |
Pulmonary embolism after SARS-CoV-2 vaccination
|
Zethelius, Björn |
|
|
21 |
C |
p. |
artikel |
14 |
Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada
|
Lu, Jessica |
|
|
21 |
C |
p. |
artikel |
15 |
Social network characteristics of COVID-19 vaccination and preventive health behaviors: Cross-sectional findings from the US northeast during the early COVID-19 pandemic
|
Khanna, Aditya S. |
|
|
21 |
C |
p. |
artikel |
16 |
The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina
|
Urueña, Analía |
|
|
21 |
C |
p. |
artikel |
17 |
The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review
|
Untung, T. |
|
|
21 |
C |
p. |
artikel |
18 |
The importance of quality of health campaign information for outcome evaluation. A case study from Guinea-Bissau and Bangladesh
|
Nielsen, Sebastian |
|
|
21 |
C |
p. |
artikel |
19 |
Trust in the science behind COVID-19 vaccines as a driver of vaccine acceptance in the United States, 2021–2023
|
White, Trenton M. |
|
|
21 |
C |
p. |
artikel |
20 |
Typhoid conjugate vaccine implementation in India: A review of supportive evidence
|
Mogasale, Vijayalaxmi V. |
|
|
21 |
C |
p. |
artikel |